Spanish cosmetic actives producer Vytrus Biotech has achieved the approval of its first patent in Europe, United States and Japan.
The stock market-listed company has been granted with a patent in the field of hair loss prevention and treatment, framed within the proprietary firm’s biotechnology platform called Phyto-Peptidic Fractions.
Through this platform, Vytrus has developed several active ingredients from plant stem cells for applications in skincare and haircare.
The patent covers the activity of one of its cosmetic innovations – Capilia Longa.
This 100% natural active from turmeric stem cells is full of plant growth factors (plant peptides) that re-activate the hair growth, nourish the hair, as well as regenerate the hair follicle in a global approach based on nature and a sustainable and efficient biotechnology.
“This triple patent approval is an international recognition of the uniqueness of the Phyto-Peptidic Fractions technology successfully developed by Vytrus,” a spokesman said.
“A milestone for the biotechnology company that promotes its guarantee, solidity and confidence in front of its clients, distributors, shareholders and collaborators,” he added.
